$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Controlled release systems and low dose androgens 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A01N-045/00
  • A61K-031/56
출원번호 US-0398096 (1995-03-03)
발명자 / 주소
  • Labrie Fernand (Quebec CAX) Lepage Martin (Quebec CAX)
출원인 / 주소
  • Endorecherche Inc. (Quebec CAX 03)
인용정보 피인용 횟수 : 21  인용 특허 : 17

초록

Methods of treatment and prevention of estrogen-related diseases, and of fertility control, include low dose (e.g. less than 50 nanomolar serum concentration)administration of certain anabolic steroids, progestins and other substantially non-masculinizing androgenic compounds. Sustained release form

대표청구항

A method of treating or preventing endometrial cancer comprising administering to a patient in need of such treatment or prevention, an effective amount of sustained release particles, with or without additional pharmaceutical carriers or diluents, said particles comprising an androgenic steroid sel

이 특허에 인용된 특허 (17)

  1. Labrie Fernand (2735 boul. Ligeois Ste-Foy ; Quebec CAX G1W 1Z9), Combination therapy for selected sex steroid dependent cancers.
  2. Labrie Fernand (2735 boul Liegeois St-Foy ; Quebec ; G1W 1Z9 CAX), Combination therapy for treatment of female breast cancer.
  3. Urquhart John (Palo Alto CA) Theeuwes Felix (Los Altos CA), Intestine drug delivery.
  4. Plunkett Earl R. (London CAX) Wolfe Bernard M. J. (London CAX), Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progesto.
  5. Bayless ; Robert G., Method of producing microcapsules and resulting product.
  6. Chatterton ; Jr. Robert T. (River Forest IL), Method of totally suppressing ovarian follicular development.
  7. Nuwayser Elie S. (Wellesley MA), Method of transdermal drug delivery.
  8. Labrie Fernand (2735 boul Liegeois St-Foy ; Qubec ; G1W 1Z9 CAX), Method of treatment of prostate cancer.
  9. Labrie Fernand (Quebec CAX), Methods of treating or preventing breast or endometrial cancer with low dose non-masculinizing androgenic compounds.
  10. DeLuca Patrick P. (Lexington KY) Kanke Motoko (Fukuyama JPX) Sato Toyomi (Tokyo CA JPX) Schroeder Hans G. (Encinitas CA), Porous microspheres for drug delivery and methods for making same.
  11. Rauleder Hartwig (Rheinfelden DEX) Ktzsch Hans-Joachim (Rheinfelden DEX) Vahlensieck Hans-Joachim (Wehr DEX), Process for the preparation of asymmetric terminally mono-unsaturated glycol ethers.
  12. Fong Jones W. (Parsippany NJ), Processes for preparation of microspheres.
  13. Gupta Kashmiri L. (San Clemente CA), Time release protein.
  14. Labrie Fernand (Quebec CAX) Raynaud Jean-Pierre (Paris FRX), Treatment method.
  15. Johnson ; Edwin Samuel ; Seely ; John Hunter, Treatment of a mammary or DMBA inducible tumor.
  16. Labrie Fernand (2735 boul Liegeois St. Foy ; Quebec ; G1W 1Z9 CAX) Blanger Alain (4031 Bois Verdun Cap-Rouge PQ ; Quebec ; G0A 1K0 CAX) Dupont Andr (3371 Chemin St. Louis St. Foy ; Quebec ; G1W 1S1 C, Treatment of breast cancer by combination therapy.
  17. Hirvonen Erkki (Helsinki FIX) Gordin Ariel (Espoo FIX), Treatment of postmenopausal disorders.

이 특허를 인용한 특허 (21)

  1. Hill, Edward N.; Sancilio, Frederick D.; Whittle, Robert R., (3) and (6) substitued estrogenic compounds.
  2. Hill,Edward N.; Sancilio,Frederick D.; Whittle,Robert R., (3) and (6) substituted estrogenic compounds.
  3. Holick, Michael F.; Kanis, John, Androgen derivatives and uses thereof.
  4. Holick, Michael F.; Kanis, John, Androgen derivatives and uses thereof.
  5. Hill,Edward N.; Leonard,Thomas W.; Whittle,Robert R., C(14) estrogenic compounds.
  6. Buch-Rasmussen, Thomas; Flink, James M.; Poulsen, Jens Ulrich; Aasmul, Søren; Hansen, Philip; Mortensen, Claus Juul, Dry mouldable drug formulation.
  7. Buch-Rasmussen, Thomas; Flink, James M.; Poulsen, Jens Ulrich; Aasmul, Søren; Hansen, Philip; Mortensen, Claus Juul, Dry mouldable drug formulation.
  8. Hill, Edward N.; Sancilio, Frederick D.; Whittle, Robert R., Estrogenic compounds and pharmaceutical formulations comprising the same.
  9. Hill,Edward N.; Sancilio,Frederick D.; Whittle,Robert R., Estrogenic compounds and topical pharmaceutical formulations of the same.
  10. Hill, Edward N.; Sancilio, Frederick D.; Whittle, Robert R., Estrogenic compounds, methods of using and methods of administering the same.
  11. Hill, Edward N.; Sancilio, Frederick D.; Whittle, Robert R., Estrogenic compounds, pharmaceutical compositions and formulations comprising the same.
  12. Hill, Edward N.; Sancilio, Frederick D.; Whittle, Robert R., Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same.
  13. Cady,Susan Mancini; Macar,Claude; Gibson,John W., Extended release growth promoting two component composition.
  14. Bell, Robert G., Method for treating osteoporosis in castrated prostatic cancer patients.
  15. Labrie, Fernand, Pharmaceutical compositions.
  16. Labrie, Fernand, Pharmaceutical compositions.
  17. Labrie, Fernand, Pharmaceutical compositions.
  18. Hill, Edward N.; Leonard, Thomas W.; Sancilio, Frederick D.; Schlipp, Katherin M.; Shirazi, Dean G.; Whittle, Robert R., Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds.
  19. El-Alfy, Mohamed; Labrie, Fernand; Berger, Louise, Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women.
  20. El-Alfy, Mohamed; Labrie, Fernand; Berger, Louise, Sex steroid precursors alone or in combination with selective estrogen receptor modulators for the prevention and treatment of dyspareunia in postmenopausal women.
  21. Hansen, Henrik Egesborg; Buch-Rasmussen, Thomas; Sabra, Mads Christian, Solid dose micro implant.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로